Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Dapagliflozin Tetraacetate is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Dapagliflozin Tetraacetate usage and description
Dapagliflozin Tetraacetate is a medication used to treat type 2 diabetes. It belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. These drugs work by blocking the reabsorption of glucose in the kidneys, which leads to increased glucose excretion in the urine and helps lower blood sugar levels.
Chemically, Dapagliflozin Tetraacetate is a white to off-white powder that is soluble in water and ethanol. It is a derivative of dapagliflozin, which is the active ingredient in the drug Farxiga. The tetraacetate form is a more stable and easier to handle form of dapagliflozin.
The recommended dosage of Dapagliflozin Tetraacetate is 10 mg once daily, taken with or without food. It should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Common side effects of the medication include urinary tract infections, genital yeast infections, and increased urination.
Dapagliflozin Tetraacetate should be used with caution in patients with impaired kidney function, as it can increase the risk of dehydration and kidney damage. It should also be avoided in pregnant or breastfeeding women, as the safety of the medication in these populations has not been established.
Overall, Dapagliflozin Tetraacetate is a useful medication for managing type 2 diabetes and can help improve blood sugar control. However, it should only be used under the guidance of a healthcare provider and with careful monitoring of kidney function and potential side effects.
